Calcium channel blockers

Consensus amid controversy

Mahendr S. Kochar Dr Kochar is chief of hypertension and associate chief of staff for education, Zablocki Veterans Affairs Medical Center, and professor of medicine and pharmacology/toxicology, Medical College of Wisconsin, MilwaukeeCorrespondence[email protected]

, MD &

M. Ismail Qurashi Dr Qurashi is a resident in medicine, Medical College of Wisconsin Affiliated Hospitals.

, MD

PREVIEW

Although the calcium channel blockers have been used to treat hypertension for a number of years, they are now under close scrutiny because of disturbing findings regarding their safety. Drs Kochar and Qurashi sort out the controversies surrounding these widely used drugs and make recommendations based on current consensus.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Calcium channel blockers

Consensus amid controversy

Information for

Open access

Opportunities

Help and information

Calcium channel blockers

Consensus amid controversy

PREVIEW

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature